Cited by 475Hepatitis C virus researchHealth Promotion and Cardiovascular PreventionLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

Moyer, Virginia A.·2013·Annals of Internal Medicine

DOI 10.7326/0003-4819-159-5-201309030-00672

Open this paper in CoChat — free account

Abstract

DESCRIPTION: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for and treatment of hepatitis C virus (HCV) infection in asymptomatic adults. METHODS: The Agency for Healthcare Research and Quality commissioned 2 systematic reviews on screening for and treatment of HCV infection in asymptomatic adults, focusing on evidence gaps identified in the previous USPSTF recommendation and new studies published since 2004. The evidence on screening for HCV in pregnant women was also considered. POPULATION: This recommendation applies to all asymptomatic adults without known liver disease or functional abnormalities. RECOMMENDATION: The USPSTF recommends screening for HCV infection in persons at high risk for infection. The USPSTF also recommends offering 1-time screening for HCV infection to adults born between 1945 and 1965. (B recommendation).

Integrity signals

Registry

Crossref · 10.7326/0003-4819-159-5-201309030-00672

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2008) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,986
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H. H., Dufour, J., Lammert, F., Duarte‐Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,507
Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease
(U.S.), C. F. D. C. A. P. (1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,217
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
Morgan, R. L., Baack, B. N., Smith, B. D., Yartel, A. K., Pitasi, M. A., & Falck-Ytter, Y. T. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 849
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
Backus, L. I., Boothroyd, D. B., Phillips, B. R., Belperio, P. S., Halloran, J. P., & Mole, L. A. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.004 · Cited by 484
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Chou, R., & Wasson, N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00005 · Cited by 372
The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings
Rein, D. B., Smith, B. D., Wittenborn, J. S., Lesesne, S. B., Wagner, L. D., Roblin, D. W., Patel, N., Ward, J. W., & Weinbaum, C. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-4-201202210-00378 · Cited by 302
American Gastroenterological Association Medical Position Statement on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.011 · Cited by 225
Three Broad Modalities in the Natural History of Vertically Acquired Hepatitis C Virus Infection
The European Paediatric Hepatitis C Virus Network (2005) · Clinical Infectious Diseases · doi:10.1086/430601 · Cited by 191

Show all 18 references

Research works printed but not linked: 3

Smith BD, 2011, Hepatology, 54, 554A
1998, MMWR Recomm Rep, 47, 1
Smith BD, 2012, MMWR Recomm Rep, 61, 1

Sorted by citations

Items 401–475 of 475

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: Rationale and Design of a Multi-Center Pragmatic Randomized Clinical Trial of Hepatitis C Screening in Emergency DepartmentsPreprint
Haukoos, J. S., Rowan, S. E., Galbraith, J. W., Rothman, R. E., Hsieh, Y., Hopkins, E., Houk, R., Toerper, M. F., Kamis, K. F., Morgan, J. R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-970694/v1 · Cited by 2
Cost–benefit analysis of universal screening for HCV infection in China: a Markov modelling study
Zhou, D., Xu, L., Zhong, Y., Xu, Z., Wang, J., Wang, Y., Gao, Y., Xie, J., Xia, Y., & Tang, W. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13349-6 · Cited by 1
“A minor quality-adjusted life-year (QALY) loss was assumed to result from universal screening [26–29].”
Interferon (IFN) Based Treatment of African Americans with Chronic Hepatitis C (CHC) in an Urban Clinic: Improving Response with Advances in Therapy
Naylor, P. H., Alebouyeh, N., Mutchnick, S. A., Bastien, M., Ehrinpreis, M. N., May, E., & Mutchnick, M. G. (2015) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2015.04.482 · Cited by 1
New all oral therapy for chronic hepatitis C virus (HCV): A cost-benefit analysis
Orsi, J., Einodshofer, M., Kirkham, H. S., Glover, P., & DuChane, J. (2014) · Value in Health · doi:10.1016/j.jval.2014.03.223 · Cited by 1
Conceptual framework for outcomes research studies of hepatitis C: an analytical review
Kaufman, A., Sbarigia, U., Denee, T. R., Turner, N., Wan, G. J., Morrison, A., Rice, G. K., & Dusheiko, G. M. (2016) · Infection and Drug Resistance · doi:10.2147/idr.s99329 · Cited by 1
“The World Health Organization’s (WHO) guideline includes only five measures in the pretreatment, preventative, and treatment categories.(4) Process-of-care measures as performance measures Performance measures, also referred to as “quality-of-care” measures, are specific metrics used to assess the quality of medical c…”
CROI 2015: Highlights of Viral Hepatitis Therapy.
Luetkemeyer, A. F., & Wyles, D. L. (2015) · Europe PMC (PubMed Central) · Cited by 1
Prevalence of Hepatitis C Screening in an HIV Primary Care Clinic
Ambrose, P., Zepf, R., Parrott, A. H., & Dawson-Rose, C. S. (2016) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2016.10.008 · Cited by 1
“The hepatitis C virus (HCV) is the most common cause of liver disease in the United States (Moyer, 2013) and a principal source of morbidity and mortality for people living with HIV infection (PLWH; Centers for Disease Control and Prevention [CDC], 2014).”
Background
Hepatitis C infection
Pozza, R., Hill, C., Hefner, A. M., Vawter, B., & Hassanein, T. (2017) · The Nurse Practitioner · doi:10.1097/01.npr.0000515423.38284.28 · Cited by 1
Testing Baby Boomers for Hepatitis C Virus Infection
Lushniak, B. D. (2014) · Public Health Reports · doi:10.1177/003335491412900302 · Cited by 1
Improving Hepatitis C Screening Rates in an Ambulatory Clinic: an Observational Study
Essrani, R. K., Nellis, E. D., & Shah, H. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05363-2 · Cited by 1
USPSTF 2020 Hepatitis B Screening Recommendation
Hwang, J. P., & Lok, A. S.-F. (2020) · JAMA · doi:10.1001/jama.2020.18831 · Cited by 1
The predominance of Hepatitis C Virus Genotypes and Its Association with the Viral Load in Bangladeshi Population
Sufian, A., Majumder, A. K., Taher, M. A., Khaleque, M. A., Akhteruzzaman, S., & Hasan, K. N. (2021) · Bioresearch Communications · doi:10.3329/brc.v7i1.54249 · Cited by 1
Direct-acting antiviral retreatment patterns for hepatitis C
Hasan, S. A., Dauner, D. G., Rajpurohit, A., & Farley, J. F. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.28.10.1100 · Cited by 1
The Efficacy of On-Site Integration Screening and Microelimination Programs for Chronic Hepatitis C in a Detection Center: A Comparison of the Treatment Outcomes and Characteristics of Incarcerated Patients and Outpatients
Chang, H.-Y., Wang, S., Kuo, H., Sheu, M., Feng, I., Ho, C., Chen, J., Sun, C., Chen, C.-H., Lin, C.-Y., et al. (2024) · International Journal of Hepatology · doi:10.1155/2024/3184892 · Cited by 1
“The US Preventive Services Task Force [21] and the WHO [22] recommend that all incarcerated persons undergo HCV testing.”
Background
HCV Health Policy Developments in Response to the National Viral Hepatitis Action Plan: A Brief Update
Guo, Y., & Sims, O. T. (2016) · Social Work in Public Health · doi:10.1080/19371918.2016.1188745 · Cited by 1
“Subsequently, in 2013 the United States Preventive Services Task Force (USPSTF) endorsed the CDC’s birth-cohort HCV testing policy by upgrading HCV testing from a grade D designation to a grade B designation (Moyer, 2013).”
Method
Hepatitis C testing among adults born between 1945 and 1965 in Turkey: a multicentre study
Altındiş, M., Demiray, T., Köroğlu, M., Atasoy, A. R., Keşli, R., Tosun, S. Y., Özdemir, M., Aksözek, A., Ece, G. T., Çetinkol, Y., et al. (2018) · Central European Journal of Public Health · doi:10.21101/cejph.a4502 · Cited by 1
Increased HCV Screening Yields Discordant Gains in Diagnoses Among Urban and Rural Veteran Populations in Texas: Results of a Statewide Quality Improvement Initiative
Wray, D., Coppin, J. D., Scott, D., Jacob, D. A., & Jinadatha, C. (2018) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2018.06.005 · Cited by 1
Update on Hepatitis C Screening and Management: Actions for Emergency Departments
Dan, C., & Kaplowitz, L. G. (2019) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-019-00183-4 · Cited by 1
Self-reported hepatitis C(HCV) testing among people living with human immunodeficiency virus (PLWH)
Kamara, M. T. B., Richards, V. L., Somboonwit, C., Park, H., Seneadza, N. A. H., Zhou, Z., Jayaweera, D. T., Thomas, E., & Cook, R. L. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07727 · Cited by 1
HIV and Hepatitis C in Corrections: A Public Health Opportunity
Bick, J. A. (2021) · Springer eBooks · doi:10.1007/978-1-0716-1807-3_8 · Cited by 1
Recent Electrochemical Methods Proposed for the Detection of Hepatitis C Virus. A Minireview
Ilie‐Mihai, R., Staden, R. S., van Staden, J. F., & Aboul-Enein, H. Y. (2022) · Revista de Chimie · doi:10.37358/rc.22.2.8515 · Cited by 1
Efectividad clínica, seguridad y evaluación económica del cribado poblacional de hepatitis C. Revisión Sistemática.
Llanos-Méndez, A., Linde, J. M. M., Cerezo-Hidalgo, C., & Márquez-Peláez, S. (2022) · doi:10.52766/cnnc1740 · Cited by 1
[Hepatitis C: pending challenges].
Montes Teves, P. (2014) · PubMed · Cited by 1
Laboratory Methods in Liver Pathology DiagnosisPreprint
Chesca, A. E., Medetova, A., Abdulina, G. A., Kouchebekov, B., Ahmetova, S., & Sandle, T. (2023) · Preprints.org · doi:10.20944/preprints202201.0226.v3
Laboratory Methods for Ill Liver AnalyzePreprint
Chesca, A. E. (2024) · Preprints.org · doi:10.20944/preprints202312.0919.v5
Healthcare costs and resource utilization in treated versus untreated chronically infected hepatitis C patients
Kim, Y. A. (2014) · Texas ScholarWorks (Texas Digital Library)
A Functional Polymorphism in the Epidermal Growth Factor Gene Independently Predicts Clinical Decompensation in HCV-Related Cirrhosis
Johnson, K. B. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Treatment of Hepatitis C Virus Infection
Shah, N. L., Kelly, V. L., & Caldwell, S. H. (2015) · Annals of Internal Medicine · doi:10.7326/l15-5064-2
Hepatitis C in Hospital Medicine
Ronan, M. V. (2015) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2014.11.003
Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era
Teriaky, A., & Reau, N. S. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.06.001
PreviousExposuretoHCVAmongPersonsBornDuring 1945-1965:PrevalenceandPredictors,UnitedStates, 1999-2008
Smith, B. D., Beckett, G. A., Holtzman, D. J., Patel, N., & Ward, J. W. (2014)
25 yeArs of hePATiTis c: uPdATed concePTs And TreATmenT
Gibas, A. L. (2014)
Should Family Physicians Routinely Screen Patients for Hepatitis C? Yes: Screening Makes Sense for High-Risk Adults.
Ghany, M. G. (2016) · PubMed
Does SVR Prevent Transplant in HCV?
Jackson, W. E., & Verna, E. C. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0288-8
Hepatitis C Risk Factors in a Cambodian American Population in Lowell, Massachusetts
Yu, C., Gifford, A. L., Christiansen, C. L., & Drainoni, M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv133.756
New Screening Recommendations for Hepatitis C Virus Infection
Moloo, J. (2013) · Journal watch · doi:10.1056/nejm-jw.na31476
Substance Use and Co-Occurring Infections: An Overview
Khalsa, J. H., Bough, K. J., Chand, N., Gyaw, S., & Lao, G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_82
Commentary
Liang, S. Y. (2014) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2014.02.002
Management of Chronic Hepatitis C Virus Infection: Current Perspectives
Mustafa, M., Menon, J., Illzam, E., Sharifa, A., Muniandy, R., & Nornazirah, A. (2016) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1509098895
Sexually Transmitted Infections in Men Who Have Sex with Men
Wagoner, N. V., & Mayer, K. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-56694-8_11
Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics
Hossain, N., Puchakayala, B. K., Kanwar, P., Verma, S. S., Abraham, G. M., Ivanov, Z., Niaz, M. O., & Mohanty, S. R. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4754-0
“It is the leading cause of complications from chronic liver disease in the USA and accounts for more than one-third of all liver transplants [4].”
Background
Insights into Hepatitis C Transmission in Young Persons who Inject Drugs: Results From a Dynamic Modeling Approach Informed by State-Level Public Health Surveillance DataPreprint
Gicquelais, R. E., Foxman, B., Coyle, J. R., & Eisenberg, M. C. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/193185
Computer simulations in health policy: methodology and applications in the management of chronic diseases
Kabiri, M. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
CLINICAL FACTORS ASSOCIATED WITH HEPATITIS C TREATMENT SELECTION IN A VETERANS AFFAIRS POPULATION
Ranson, C. A. (2017) · Scholarly Commons (University of the Pacific)
MODELING CHRONIC HEPATITIS C DURING RAPID THERAPEUTIC ADVANCE
Liu, S. (2018) · Wiley eBooks · doi:10.1002/9781118960158.ch6
Short-Term Incidence of Sequelae of HCV Infection Among Medicaid Beneficiaries in Oregon
Jindai, K., Crawford, C., & Thomas, A. R. (2018) · Public Health Reports · doi:10.1177/0033354918813552
Hepatitis C Virus Among Pregnant Women and Children in the USA: an Emerging Epidemic
Chappell, C. A., & Krans, E. E. (2018) · Future Virology · doi:10.2217/fvl-2018-0147 · Cited by 1
Impact of HCV antiviral therapy on the Liver Transplantation Waiting-List assessed by mathematical models
Chaib, E., Pessoa, J. L. E., Medeiros, M., & Massad, E. (2019) · Journal of Surgery and Surgical Research · doi:10.17352/2455-2968.000058
PROTECT YOUR LIVER FROM HEPATITIS
Tilak, A., Thakur, R., Gangwar, S. S., & Sharma, R. P. (2018) · International Journal of Medical & Pharmaceutical Sciences
Gastrointestinal Health and Healthy Aging
Siddappa, P. K., & Birk, J. W. (2019) · Springer eBooks · doi:10.1007/978-3-030-06200-2_7
Optimizing infectious disease control
Heil (2018) · doi:10.26481/dis.20181025jh
mHealth can Activate Patients to Discuss Hepatitis C Screening with Physicians
Kellogg, J. B., Lee, J. D., Murphy, D. R., & Arya, M. (2019) · Journal of Mobile Technology in Medicine · doi:10.7309/jmtm.8.1.3
“Preventive Services Task Force (USPSTF) recommend HCV screening for many at-risk populations, including the 1945 to 1965 birth cohort (“baby boomers”).(2,3) Despite longstanding HCV screening recommendations and the success of oral direct acting antivirals (DAAs), which can reverse the natural progression of HCV, 45-8…”
Background
Results of Direct-Acting Antiviral Therapy in Chronic Hepatitis C Patients Undergoing Hemodialysis
Istanbul Egitim ve Arastirma Hastanesi, I. H. V. K. M. K., Sarı, N. D., Köse, Ş., Istanbul Egitim ve Arastirma Hastanesi, H. U., İnci, A., & Istanbul Egitim ve Arastirma Hastanesi, I. H. V. K. M. K. (2020) · Klimik Dergisi/Klimik Journal · doi:10.5152/kd.2020.08
Health Maintenance and Preventive Care in Older Adutls with Dementia
Braun, U. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-46398-4_14
Using the endoscopy suite of an urban medical center for efficient identification of patients with HCV and linkage to care
Naylor, P. H., Abu-Heija, A., Mohamad, B., Tama, M., Kathi, P. R., Nayeem, M., Khalid, M., Kaloti, Z., Kutaimy, R., Ehrinpreis, M. N., et al. (2019) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2019.10.00403
Age‐ and risk factor–based serologic screening for Hepatitis C virus among an Urban, high‐risk population
Dimova, R. B., Rude, E. J., & Talal, A. H. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13359 · Cited by 1
Characterization of patients with chronic hepatitis C attended at a hepatology clinic of a community hospital in North Brooklyn in New York City
Bergasa, N. V., Roshan, P., Shady, A., Alansari, T. H., Albina, A., Istafanos, V., & Yvonne, N. (2020) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2020.11.00430
Tamización para el virus de la hepatitis C en tres hospitales de Cundinamarca, Colombia
Garzón-Olarte, M., Marín, J. D. M., T, M. H. R., & Cabra-Ballesteros, A. L. (2021) · Hepatología · doi:10.52784/27112330.130
Ambulatory Medication Safety: Vaccination and Laboratory Screening for Patients Receiving Immunomodulatory Therapies
McDonnell, A., Iversen, M. D., Khinkar, R. M., Frits, M. L., Fiskio, J. M., & Desai, S. P. (2021) · Arthritis Care & Research · doi:10.1002/acr.24764
Hepatitis C
Fried, M. W., Darling, J. M., & Lemon, S. M. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch25
Diagnosis
Goossens, N., Clément, S., & Negro, F. (2016) · Springer eBooks · doi:10.1007/978-3-319-28053-0_5
Faculty Opinions recommendation of Hepatitis C testing increased among baby boomers following the 2012 change to CDC testing recommendations.
Terrault, N. A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734549305.793553779
Bibliographies
(2020) · Springer Publishing Company eBooks · doi:10.1891/9780826173270.ap08
References
(2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817436-4.16001-1
Colorectal Cancer Screening Program in Songjiang district, Shanghai between 2015 and 2017: Evaluation of participation rate and the associated factor
Wu, Y., Saito, H., Ozaki, A., Tanimoto, T. E., Jiang, Y., Yang, P., Li, J., Zhou, Z., Zhu, X., Lu, F., et al. (2022) · Medicine · doi:10.1097/md.0000000000029259
“There is a wide range of diseases and conditions to be screened for, including communicable diseases[1,2] and noncommunicable diseases such as cancers.”
Background
Management of hepatitis C virus (HCV) infection: an update
Ștefan, I., Ștefani, C., Sîrbu, C. A., Axelerad, A. D., & Radu, F. I. (2022) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2022.125.3.7
Sociodemographic Predictors of Viral Load Testing Among Hepatitis C Antibody-Positive Patients in a Large Southern California County: An Example of Health Care Inequalities
Goodman, S. H., Zahn, M., Bruckner, T. A., Boden-Albala, B. M., Hankin, J. R., & Lakon, C. M. (2023) · Emerald Group Publishing Limited eBooks · doi:10.1108/s0275-495920230000040008
Opioid Use Disorders: Prevention, Diagnosis, and Treatment Strategies to Mitigate Addiction Risks
Agarwal, U., Singhal, K., & Tonk, R. K. (2025) · Current Drug Safety · doi:10.2174/0115748863357891250213094516
Predicting Liver Cancer Risk Using Comprehensive Medical History
Sosorburam, T. (2025) · Quality Management in Health Care · doi:10.1097/qmh.0000000000000521
“Additionally, all pregnant women are recommended to be screened for HBV. 14 , 15 While current treatments for liver cancer are limited, ongoing research and advancements in medical technology may hold promise for the future, such as improving and expanding early detection based on patient risk…”
Screening for Viral Hepatitis to Reduce the Incidence of Liver Cancer
Negro, F. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.115653
Regional Differences of Hepatitis C Virus Infection in Kentucky
Achuo-Egbe, Y. (2015) · UKnowledge (University of Kentucky)
Additional file 1 of The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments
Haukoos, J. S., Rowan, S. E., Galbraith, J. W., Rothman, R. E., Hsieh, Y.-H., Hopkins, E., Houk, R., Toerper, M. F., Kamis, K. F., Morgan, J. R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19656860
Epidemiological and socio-behavioral risk factors associated with transmission of lymphogranuloma venereum
Titov, I. S., Guschin, A. E., Frigo, N. V., Dolya, O. V., & Жукова, О. В. (2025) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202524061742
Associations Between Patient Language Preference and Hepatitis C Screening: Results From the DETECT Hep C Emergency Department Screening Trial
Thiessen, M. E. W., Haukoos, J., Hopkins, E., Galbraith, J. W., Rothman, R. E., Bacon, E., Prochazka, A. V., Jones, A., Rast, J. E., Lyle, C., et al. (2026) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2026.08.730
Cardiomyopathy due to Pegylated Interferon Therapy for Hepatitis C
Kaveti, P., Isom, E. T., Schrapp, K., & Crawford, M. (2014) · International Journal of Internal Medicine

Authors: Moyer, V. A.
Affiliations: United States Preventive Services Task Force (US)
Corresponding author: Moyer, Virginia A.
ORCID: Moyer, Virginia A.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 2013-09
Volume: 159
Issue: 5
Pages: 349-357
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-159-5-201309030-00672
OpenAlex: W2148959572
Cited by: 475
References: 18
Citations by year: 2026: 2 · 2025: 11 · 2024: 5 · 2023: 8 · 2022: 21 · 2021: 23 · 2020: 40 · 2019: 50 · 2018: 59 · 2017: 57 · 2016: 68 · 2015: 59 · 2014: 52 · 2013: 19
FWCI: 41.16
Type: journal article
Language: en
Open access: closed
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: hepatitis C virus, HCV screening, asymptomatic adults, vulnerable populations, hepatitis C treatment, baby boomers, screening guidelines
MeSH terms: Adult, Age Factors, Antiviral Agents, Female, Humans, Mass Screening, Pregnancy, Pregnancy Complications, Infectious, Cost of Illness, Risk Assessment, Hepatitis C, Chronic, Early Diagnosis, Asymptomatic Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks